Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Incyte Corp (INCY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,031,316
  • Shares Outstanding, K 211,660
  • Annual Sales, $ 1,536 M
  • Annual Income, $ -313,140 K
  • 36-Month Beta 0.59
  • Price/Sales 11.67
  • Price/Cash Flow 97.42
  • Price/Book 10.96

Price Performance

See More
Period Period Low Period High Performance
1-Month
80.85 +5.37%
on 02/09/18
96.44 -11.67%
on 01/24/18
-8.89 (-9.45%)
since 01/22/18
3-Month
80.85 +5.37%
on 02/09/18
102.63 -16.99%
on 01/03/18
-13.81 (-13.95%)
since 11/22/17
52-Week
80.85 +5.37%
on 02/09/18
153.15 -44.37%
on 03/15/17
-36.17 (-29.80%)
since 02/22/17

Most Recent Stories

More News
Zacks.com featured highlights include: Incyte, Altice USA, Archrock, Live Nation and PTC

Zacks.com featured highlights include: Incyte, Altice USA, Archrock, Live Nation and PTC

LYV : 47.83 (+0.99%)
INCY : 85.19 (+0.57%)
AROC : 9.10 (+2.82%)
PTC : 73.25 (+0.60%)
ATUS : 18.56 (-1.22%)
Stocks Follow Walmart Lower

Stocks Follow Walmart Lower

FCAU : 21.77 (-1.05%)
XPO : 93.56 (-0.46%)
SBH : 17.02 (-1.16%)
X : 42.98 (+0.28%)
IONS : 49.88 (+0.04%)
INCY : 85.19 (+0.57%)
CNC : 99.49 (-0.71%)
AEO : 18.86 (+0.27%)
MIK : 24.20 (-0.45%)
WMT : 92.77 (+1.37%)
Get Rid of 5 Toxic Stocks or Sell Short for Profit

Overblown toxic stocks are generally susceptible to outside shocks and are loaded with a huge amount of debt.

LYV : 47.83 (+0.99%)
INCY : 85.19 (+0.57%)
AROC : 9.10 (+2.82%)
PTC : 73.25 (+0.60%)
ATUS : 18.56 (-1.22%)
Incyte (INCY) Beats on Q4 Revenues on Strong Jakafi Sales

Incyte (INCY) beat on revenues in the fourth quarter driven by an increase in Jakafi sales. The guidance for 2018 was also encouraging.

MRK : 54.57 (+0.04%)
INCY : 85.19 (+0.57%)
NVS : 85.20 (+0.37%)
BMY : 65.94 (-0.89%)
Incyte (INCY) Beats on Sales in Q4

Incyte (INCY) beat on sales in the fourth quarter driven by growth in Jakafi sales.

INCY : 85.19 (+0.57%)
Incyte Reports 2017 Fourth-Quarter and Year-End Financial Results, Provides 2018 Financial Guidance and Updates on Key Clinical Programs

--Jakafi(R) (ruxolitinib) revenues $302 million (+27%) in Q4 2017 and $1.13 billion (+33%) in FY 2017; FY 2018 guidance $1.35-1.40 billion

INCY : 85.19 (+0.57%)
Incyte Corporation to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 15, 2018 / Incyte Corporation (NASDAQ: INCY) will be discussing their earnings results in their Q4 Earnings Call to be held on February 15, 2018 at 8:00 AM Eastern...

INCY : 85.19 (+0.57%)
Why Incyte (INCY) Might Surprise This Earnings Season

Incyte (INCY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

INCY : 85.19 (+0.57%)
Can Jakafi Performance Drive Incyte's (INCY) Q4 Earnings?

Growth in Jakafi sales are likely to help Incyte (INCY) to beat on earnings in Q4.

LLY : 77.19 (-0.46%)
INCY : 85.19 (+0.57%)
NVS : 85.20 (+0.37%)
EXEL : 29.10 (+0.38%)
Watch for Incyte Corp to Potentially Rebound After Falling 1.30% Yesterday

Incyte Corp (NASDAQ:INCY) traded in a range yesterday that spanned from a low of $81.68 to a high of $84.94. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $83.88...

INCY : 85.19 (+0.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. Their first commercial product, Jakafi (ruxolitinib), is approved in the United States for patients with intermediate or high-risk myelofibrosis...

See More

Key Turning Points

2nd Resistance Point 88.44
1st Resistance Point 86.81
Last Price 85.19
1st Support Level 84.29
2nd Support Level 83.40

See More

52-Week High 153.15
Fibonacci 61.8% 125.53
Fibonacci 50% 117.00
Fibonacci 38.2% 108.47
Last Price 85.19
52-Week Low 80.85

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.